#24 A week in the name of medicines safety – ...

Send a message to the show!Pharmacovigilance has traditionally focused on the patient at the receiving end of a medicine. But what happens to medicines once they leave the body? In this episode, Valentina Giunchi and Joe Mitchell unpack the emerging field of ecopharmacovigilance ...  Show more

Send a message to the show!For all its ease and speed, disproportionality analysis can be distorted by many biases, making it easy to misuse and misinterpret. Michele Fusaroli from Uppsala Monitoring Centre and Eugene van Puijenbroek from the Netherlands pharmacovigilance centre ...  Show more

In this podcast, Dr Emma Nash talks to Professor Tony Avery, GP, Professor of Primary Health Care at the University of Nottingham, and National Clinical Director for Prescribing. Key points from the two prescribing safety modules are touched on, in the context of the Medicines Sa ...  Show more

We begin this episode by discussing our article of the week from the New England Journal of Medicine entitled “Hydrocortisone in severe community-acquired pneumonia.“. In the second half of our episode, we bring a medical eye to popular events. We begin with a discussion about ...

We begin with a discussion about our article of the week from the BMJ, entitled prenatal opioid exposure and subsequent risk of neuropsychiatric disorders in children: nationwide birth cohort study in South Korea.

In the second half, we start off by talking about the ri ...

Vulnerable plaque and scientific method; industry payments to trainees; tirzepatide or semaglutide; trial interpretation; and PFA are the topics John Mandrola, MD, covers in today's podcast.

This podcast is intended for healthcare professionals only.

To ...